Salt Lake City, UT (November 8, 2021) 4Life recently published a scientific research manuscript in the Journal of Immunological Methods
: “Method development for the analysis of PBMC-mediated killing of K562 cells by bovine colostrum.”
4Life’s Research & Development department began work on the study in 2019. The research uses a technique called flow cytometry to study Natural Killer cells in the immune system and how these cells are affected by bovine colostrum.
Lead scientist and researcher Anna Andersen: “Two years ago, our research was referenced at an Immunology Conference. To see our efforts published now in such a reputable journal is deeply satisfying.”
This latest publication further distinguishes 4Life from competitors in the areas of science, research, and publication.
Chief Science Officer Dr. David Vollmer: “What an achievement. Anna Andersen has been with this study since the beginning, and we’re so happy for her and the whole team. It’s rewarding to read about our star ingredient, 4Life Transfer Factor, in a third party publication. This research will serve as a platform for us to continue our immune system research in the future.”
4Life, the Immune System Company™
, and the first to bring 4Life Transfer Factor®
research to market, has offices in 25 markets to serve the company’s worldwide customers.
For more information:
Vice President Corporate Communications